GLP-1 weight-loss drugs like semaglutide help people eat less by strengthening the brain’s “I’ve had enough food” signal. This study suggests one reason weight loss may slow down or plateau: in some brain cells, that signal does not stay strong. The drug boosts a molecule called cAMP inside appetite-related neurons, but in some cells the signal fades instead of staying active. Researchers found that an enzyme called PDE4 may be involved because it breaks down cAMP. When they blocked PDE4 in mice, the satiety-related signal lasted longer. So the simple takeaway is: GLP-1 drugs may not suddenly “fail.” Instead, the brain’s response may weaken over time as the internal fullness signal becomes harder to sustain. This could help explain why some people lose weight quickly at first, then hit a plateau. Important caveat: this was a mouse/brain-cell signaling study, not direct proof in humans yet. submitted by /u/Impressive_Pitch9272 [link] [comments]